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Background
Low birth weight has been inconsistently associated with risk of
developing affective disorders, including major depressive
disorder (MDD). To date, studies investigating possible
associations between birth weight and bipolar disorder (BD), or
personality traits known to predispose to affective disorders
such as neuroticism, have not been conducted in large
cohorts.
Aims
To assess whether very low birth weight (<1500 g) and low birth
weight (1500–2490 g) were associated with higher neuroticism
scores assessed in middle age, and lifetime history of either
MDD or BD. We controlled for possible confounding factors.
Method
Retrospective cohort study using baseline data on the 83 545
UK Biobank participants with detailed mental health and birth
weight data. Main outcomes were prevalent MDD and BD,
and neuroticism assessed using the Eysenck Personality Inventory
Neuroticism scale - Revised (EPIN-R)
Results
Referent to normal birth weight, very low/low birth weight were
associated with higher neuroticism scores, increased MDD and
BD. The associations between birth weight category and MDD
were partially mediated by higher neuroticism.
Conclusions
These findings suggest that intrauterine programming may play
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Previous studies have reported associations between low birth
weight (under 2500 g) and risk of cardiometabolic disease1 and
some psychiatric disorders.2 Associations between low birth
weight and bipolar disorder (BD) have not been reported, and
associations with personality traits such as neuroticism have only
been investigated in small studies that focused on very low birth
weight,3 extremely low birth weight4 or specifically preterm
participants5 (e.g. range n=71–158).3–5 The hypothesis of a
possible causal association with cardiometabolic disease and
psychiatric disorders has been variously termed the ‘Barker
hypothesis’, the ‘foetal origins hypothesis’ or the ‘developmental
origins of adult health and disease hypothesis’.6 This hypothesis
suggests that as a result of fetal plasticity, the fetus is able to
undergo physiological adaptations in response to an adverse
intrauterine environment; for example, poor early nutrition may
adjust glucose–insulin metabolism to maximise possible fitness.
Whereas this may potentially protect against early mortality, it
may have negative sequelae in later life, including susceptibility to
some chronic diseases.7
Low birth weight and MDD
A recent meta-analysis which pooled assessments of the associa-
tion between low birth weight and risk of major depressive
disorder (MDD) derived in 18 separate studies, comprising a total
of 59 442 participants, did not find evidence for an association
once publication bias was taken into account.2 The authors noted
significant heterogeneity between studies, including wide age
ranges of participants, different outcome measures, inadequate
follow-up rates and low power. Studies also often failed to control
for important potential confounders such as maternal smoking or
maternal MDD, socioeconomic status, gestational age, gender and
family history of MDD, and some studies included extremely low
birth weight (<1000 g) participants from specialist hospital
environments.2 We aimed to add to the literature in this area by
testing for an association between low/very low birth weight and
risk of MDD (in adulthood) using the data collected at recruit-
ment of a large population cohort (UK Biobank). We were also
able to assess the associations between birth weight and neuroti-
cism scores, and risk of BD in adulthood. Neuroticism is
recognised as a risk factor for MDD and for psychopathology in
general,8 with individuals who score highly on neuroticism
characterised as having a tendency to be less emotionally stable,
more anxious and more reactive to negative events.9
Current study
UK Biobank recruited 502 649 participants aged around 40–70
years from the general population between 2006 and 2010.10
Participants completed a touchscreen questionnaire that included
demographic information, questions on physical health, recalled
birth weight, and a battery of cognitive and mental health
inventories.
We investigated the association between birth weight and each
of: neuroticism, MDD and BD. The advantages of using the UK
Biobank cohort for this assessment include the large sample size,
extensive information on possible covariates/confounders (e.g.
maternal smoking) and mediators (e.g. cardiovascular disease),
and consistent measurement in terms of outcome variables
(compared with meta-analysis, which pools studies with different
approaches).
The objectives of this study were: to test for an association
between birth weight category and each outcome; to determine
whether there was evidence of a dose-effect across very low
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(<1500 g), low (1500–2490 g) and normal (≥2500 g) birth weight;
to determine whether any associations persisted after adjustment
for potential confounding variables; and to explore whether
physical health and neuroticism had possible mediating roles in
the associations with MDD and BD, using formal tests of
mediation for the latter.11,12
Method
All participants attended 1 of 22 assessment centres. Participants
were asked to report their birth weight (either in kilograms
directly, or in pounds and ounces and converted to kilograms to
two decimal points) and whether they had any physical disorders,
including hypertension, heart/cardiac problems, stroke, peripheral
vascular disease, type 2 diabetes, chronic obstructive pulmonary
disease (COPD) and osteoporosis. Participants self-reported
whether their mothers had ever had MDD (at any time), and
whether their mothers smoked around the time of pregnancy. We
coded ‘White’ ethnicity for participants who reported themselves at
assessment as ‘White’, ‘White-British’, ‘White-Irish’ or ‘Any other
White background’,13 and Black and minority ethnic for the
remainder. Townsend scores were obtained from postcode of
residence. They are an area-based index of socioeconomic depriva-
tion derived from census data on car ownership, household
overcrowding, owner-occupation and unemployment.14 Higher
Townsend scores equate to greater socioeconomic deprivation.
Neuroticism was assessed with 12 questions from the Eysenck
Personality Inventory Neuroticism scale - Revised (EPIN-R15,16)
and the 172 751 participants recruited in the past 2 years were
asked to provide more detailed information on lifetime experience
of mood disorder features and were grouped into probable MDD
or probable BD (or not) based on a structured classification which
we have previously described in detail.16 Briefly, current and past
depressive features were assessed by items relating to lifetime
experience of minor/major depression, items from the Patient
Health Questionnaire (PHQ) and items related to mental health
help-seeking.16,17 Probable history of BD was based on questions
in the baseline self-report assessment which were analogous to
questions within the Structured Clinical Interview for DSM-IV
Disorders (SCID-118). If participants had probable BD and also
probable MDD, they were classified as BD only.
This study was conducted under generic approval from the
NHS National Research Ethics Service (approval letter ref 11/
NW/0382).
Statistical analyses
For the analyses of birth weight and neuroticism, we used linear
regression. Neuroticism scores were positively skewed, and log/
square root transformations did not improve the distribution; we
report linear regression statistics because the final results were not
meaningfully different from Spearman non-parametric correlations
(not shown) but are easier to interpret, and assumptions of
normality are to an extent eased in very large data-sets.19 Because
the MDD and BD groups had significantly higher neuroticism
scores, as would be expected (both P<0.001), we removed partici-
pants with either of these disorders from the neuroticism analyses.
We used Poisson regression to estimate relative risk (RR)
ratios for the MDD and BD analyses in relation to birth weight.
RR ratios are preferable to odds ratios when the outcome is not
rare (i.e. >10%) in the population, as odds ratios are poor
estimates of RRs in such circumstances, and are harder to
interpret.20 P-values less than 0.05 were considered statistically
significant. All analyses were conducted with IBM SPSS V.22,
except for Fig. 1 which was made by using STATA SE v.13.
We found a positive association between year of birth and
birth weight in kilograms, controlling for maternal smoking and
maternal depression (r=0.01, P<0.001) suggesting a possible birth
cohort effect. We tested each association unadjusted for covariates,
and then adjusted for possible confounding variables: year of birth
(i.e. controlling for possible age and birth cohort effects), Town-
send deprivation score, White v. Black and minority ethnic,
gender, maternal smoking and maternal depression. Finally,
because physical disorders can be risk factors for psychiatric
disorders21 and are, therefore, potential mediators, for the MDD
and BD analyses we added the covariates of hypertension, cardiac
disease, stroke, peripheral vascular disease, type 2 diabetes, COPD
and osteoporosis. For each model, we first tested for an overall
deleterious very low>low>normal birth weight dose effect, and
then for an effect of birth weight group (very low/low) v. normal
weight as the referent category.
We formally tested whether significant birth weight and mood
disorder associations were mediated by trait neuroticism scores,
using the PROCESS macro.12 Briefly, the effect of a predictor
variable (e.g. birth weight group) on an outcome variable (e.g.
MDD) can be either direct or indirect via a mediator (e.g.
neuroticism). In a mediation context, a three-way association has
two products: ‘Path A’: the association between the predictor and
mediator (e.g. birth weight and neuroticism), and ‘Path B’: the
mediator and outcome association adjusted for the predictor (e.g.
association for neuroticism and MDD adjusted for birth weight).
The indirect effect is the combined product of these two paths.11,12
We used the PROCESS macro ‘Model 4’, which allows for
dichotomous independent variables/outcomes in mediation mod-
els (bootstrap n=1000, bias-corrected).
We excluded all participants who had requested withdrawal
from the UK Biobank as of March 2015. As a check, we tested for
differential recall of birth weight (i.e. data present v. not reported)
by disease status: i.e. whether participants with probable MDD/BD
or higher neuroticism were more likely to recall their birth weight;
a potential source of bias.
Results
We limited analysis to the participants with mood disorder data
(n=172 751) who also had birth weight data available (final n=83
545). Table 1 shows descriptive statistics (including prevalence
rates) stratified by birth weight category. Overall, 931 (1.1%)
participants had very low birth weight, 7320 (8.8%) low birth
weight and 75 294 (90.1%) had normal birth weight. The normal
birth weight category included 4113 participants with high birth
weight (4500 g) which can be a risk factor for cardiovascular
diseases in later life.22 Exclusion of these participants did not alter
the findings. Therefore, they were included in the normal birth
weight category in all analyses. We additionally tested for a linear
effect of birth weight in normal range participants (2500–4500 g),
and report these associations in Tables 2 and 3; however, it is
worth noting that this model assumes a linear association which
may not be the case with these phenotypes.
Neuroticism
As shown in Table 4, there was a significant dose effect (very
low>low>normal) across the birth weight categories in terms of
neuroticism scores, for both the unadjusted (P<0.001) and
adjusted models (P=0.002). Compared with the normal birth
weight group, there was a significant association between low birth
weight and higher neuroticism scores, in the unadjusted model
(unstandardised b=0.21, 95% CI 0.11–0.30, P<0.001). This
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association persisted after adjustment for possible confounding
variables (b=0.23, 95% CI 0.13–0.33, P<0.001). The magnitudes of
the associations were greater for very low birth weight in the
unadjusted (b=0.27, 95% CI 0.11–0.52, P=0.041) and adjusted
models (b=0.31, 95% CI 0.03–0.60, P=0.031).
Probable MDD
There was a significant overall birth weight dose effect for
MDD rates in the unadjusted and confounder-adjusted models
(P<0.001) Table 5. Compared with the normal birth weight group
there was a significant association between low birth weight and
Table 1 Clinical and demographic characteristicsa
Total N





(≥2500 g) n=75 294 P
Age, years: mean (s.d.) 83 545 56.70 (8.07) 56.56 (8.00) 55.33 (8.24) <0.001
Male, n (%) 83 545 327 (35.1) 2103 (28.7) 31 090 (41.3) <0.001
Black and minority ethnic, n (%) 83 324 48 (5.2) 427 (5.9) 3278 (4.4) <0.001
Neuroticism score, mean (s.d.) 71 006 4.47 (3.26) 4.18 (3.23) 3.94 (3.18) <0.001
Townsend deprivation score, mean (s.d.) 83 408 −0.67 (3.16) −1.18 (2.91) −1.38 (2.81) <0.001
Depression, n (%) 83 545 288 (31.2) 1897 (26.1) 17 650 (23.6) <0.001
Bipolar disorder, n (%) 83 545 16 (1.7) 87 (1.2) 791 (1.1) 0.085
Maternal smoking, n (%) 74 966 326 (40.5) 2317 (35.8) 18 687 (27.6) <0.001
Maternal depression, n (%) 80 197 74 (8.6) 498 (7.1) 4578 (6.3) 0.001
Hypertension, n (%) 83 545 327 (35.1) 2115 (28.9) 16 984 (22.6) <0.001
Cardiac disease, n (%) 83 545 6 (0.6) 22 (0.3) 205 (0.3) 0.095
Stroke, n (%) 83 545 25 (2.7) 89 (1.2) 732 (1.0) <0.001
Peripheral vascular disease, n (%) 83 545 1 (0.1) 6 (0.1) 40 (0.1) 0.490
Type 2 diabetes, n (%) 83 545 18 (1.9) 60 (0.8) 397 (0.5) <0.001
COPD history, n (%) 83 545 1 (0.1) 27 (0.4) 202 (0.3) 0.180
Osteoporosis, n (%) 83 545 26 (2.8) 168 (2.3) 1120 (1.5) <0.001
COPD, chronic obstructive pulmonary disease.
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Fig. 1 Relative risk ratios and 95% conﬁdence intervals for very low/low birth weight groups (v. normal weight) and probable major depressive
disorder. Normal birth weight group = referent y-axis line.
(a) Unadjusted. (b) Adjusted for year of birth, Townsend deprivation score, ethnicity, gender, maternal smoking and maternal depression (i.e. covariates). (c) Additionally adjusted for
hypertension, heart/cardiac problems, stroke, perivascular disease, type-2 diabetes, chronic obstructive pulmonary disease and osteoporosis (i.e. physical disease mediators).
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MDD in the unadjusted model (RR=1.11, 95% CI 1.06–1.15,
P<0.001). This was attenuated but remained significant after
adjusting for potential confounders (RR=1.06, 95% CI 1.02–1.11,
P=0.007). Adjustment for potential mediating physical diseases
produced little attenuation (RR=1.05, 95% CI 1.00–1.09, P=0.041).
There was a stronger association with very low birth weight in
both the unadjusted (RR=1.32, 95% CI 1.20–1.46, P<0.001) and
adjusted models (RR=1.24, 95% CI 1.11–1.37, P<0.001). Adjust-
ment for potential physical disease mediators produced greater
attenuation than for low birth weight (RR=1.19, 95% CI 1.07–1.33,
P=0.001). All RRs are shown in Fig. 1.
In Fig. 2, we show the associations (in terms of beta
coefficients and RRs) between birth weight group and mood
disorder, before and after adjustment for neuroticism scores. This
figure shows that the associations between low and very low birth
weight and probable depression, expressed in RRs respectively
attenuate by 44% (unadjusted RR=1.09, to adjusted RR=1.05) and
by 31% (RR=1.36, to 1.25) when adjusted for neuroticism,
although both remained significant. (Note that the RRs are very
slightly different in the mediation model because the macro
includes participants with complete birth weight/neuroticism/
mood data.) Formal tests of mediation showed neuroticism
significantly mediated the birth weight/MDD association with
both low birth weight (v. normal; indirect coefficient=0.05, 95% CI
0.04–0.07) and very low birth weight (v. normal; indirect
coefficient=0.06, 95% CI 0.03–0.09). Raw mediation model
statistics are provided in Table 6.11,23
Probable BD
There was a significant overall dose effect of lower birth weight in
the unadjusted (P=0.048) and confounder-adjusted model
(P=0.047), which attenuated when adjusted for potential
Table 2 Association between birth weight and neuroticism in normal range participants (2500–4500 g)
Birth weight, g
b (95% CI) P
Neuroticism
Unadjusted (n=46 110) –0.02 (–0.22 to –0.09) <0.001
Adjusted for potential confoundersa (n=41 800) –0.01 (–0.10 to 0.03) 0.328
a. Adjusted for year of birth, Townsend deprivation score, ethnicity, gender, maternal smoking and maternal depression.
Table 3 Features of depression and bipolar disorder in normal range participants (2500–4500 g)
Relative risk ratios (95% CI) P
Depression
Unadjusted (n=83 172) 0.93 (0.91–0.95) <0.001
Adjusted for potential confoundersa (n=71 591) 0.98 (0.96–1.00) 0.074
Adjusted for potential physical disease mediatorsb (n=71 591) 0.99 (0.97–1.01) 0.387
Bipolar disorder
Unadjusted (n=83 545) 0.93 (0.84–1.03) 0.187
Adjusted for potential confoundersa (n=71 953) 0.91 (0.82–1.02) 0.091
Adjusted for potential physical disease mediatorsb (n=71 953) 0.93 (0.83–1.03) 0.160
a. Adjusted for year of birth, Townsend deprivation score, ethnicity, gender, maternal smoking and maternal depression.
b. Additionally adjusted for hypertension, heart/cardiac problems, stroke, perivascular disease, type-2 diabetes, chronic obstructive pulmonary disease and osteoporosis.
Table 4 Association between low and very low birth weight and neuroticism
Low birth weight Very low birth weight
b (95% CI) P b (95% CI) P Overall dose P
Neuroticism
Unadjusted (n = 48 835) 0.21 (0.11–0.30) <0.001 0.27 (0.11–0.52) 0.041 <0.001
Adjusted for potential confoundersa (n = 46 961) 0.23 (0.13–0.33) <0.001 0.31 (0.03–0.60) 0.031 0.002
a. Adjusted for year of birth, Townsend deprivation score, ethnicity, gender, maternal smoking and maternal depression.
Table 5 Association between low and very low birth weight and features of depression and bipolar disordera




(95% CI) P Overall dose P
Depression
Unadjusted (n=83 127) 1.11 (1.06–1.15) <0.001 1.32 (1.20–1.46) <0.001 <0.001
Adjusted for potential confoundersb (n=71 591) 1.06 (1.02–1.11) 0.007 1.24 (1.11–1.37) <0.001 <0.001
Adjusted for potential physical disease mediatorsc
(n=71 591)
1.05 (1.00–1.09) 0.041 1.19 (1.07–1.33) 0.001 0.001
Bipolar disorder
Unadjusted (n=83 545) 1.13 (0.91–1.41) 0.272 1.64 (1.00–2.67) 0.049 0.048
Adjusted for potential confoundersb (n=71 935) 1.13 (0.89–1.44) 0.332 1.74 (1.05–2.87) 0.032 0.047
Adjusted for potential physical disease
mediatorsc (n=71 935)
1.10 (0.86–1.40) 0.436 1.63 (0.98–2.69) 0.058 0.089
a. All risk ratio statistics are relative to the normal birth weight group, except for the overall dose P-value which refers to an ordinal dose effect (i.e. very low>low>normal birth weight).
b. Adjusted for year of birth, Townsend deprivation score, ethnicity, gender, maternal smoking and maternal depression.
c. Additonally adjusted for hypertension, heart/cardiac problems, stroke, perivascular disease, type 2 diabetes, chronic obstructive pulmonary disease and osteoporosis.
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mediators (P=0.089). There was no evidence of association
between low v. normal birth weight group and BD rates, in any
of the unadjusted models based on P-values. For the very low v.
normal birth weight analyses, there was a significant association in
the unadjusted model (RR=1.64, 95% CI 1.00–2.67, P=0.049),
which remained significant in the confounder-adjusted model
(RR=1.74, 95% CI 1.05–2.87, P=0.032) (Table 5). Following
inclusion of the potential mediators as covariates, the association
was attenuated and no longer statistically significant (P>0.05).
Because of this, we did not investigate neuroticism as a mediator
of the very low birth weight/BD association.
Birth weight recall bias
To assess whether there was differential ability to recall birth
weight – i.e. a reporting/selection bias – we tested for association
between likelihood of reporting birth weight v. not and higher
rates of MDD/BD/neuroticism scores. Participants who provided
birth weight data were significantly more likely to have probable
MDD (RR=1.11, 95% CI 1.09–1.13, P<0.001) but not BD (P>0.05).
In healthy participants (i.e. no MDD or BD), those who provided
birth weight data had significantly lower neuroticism (b=−0.16,
95% CI −0.20 to −0.13, P<0.001).
Discussion
Main findings
Birth weight was significantly associated with neuroticism, MDD
and BD in 83 545 adults recruited from the general population.
There were clear trends whereby the risk of all three increased
with reducing birth weight, from normal to very low. Tests of
mediation showed that the association between birth weight and
MDD was partially mediated by its association with neuroticism.
We found a significant association between low birth weight
and higher neuroticism, which survived adjustment for relevant
covariates. There was a significant dose effect, such that lower
birth weight was associated with higher neuroticism in adulthood
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Fig. 2 Three-way associations between low/very low birth weight (v.
normal weight), neuroticism and probable major depressive dis-
order. Values in brackets are relative risk (RR) ratio statistics, before
controlling for neuroticism scores. ***P<0.001, **P<0.01. b =
unstandardised beta coefﬁcient. Adjusted RR = neuroticism scores
included the model. A full description of the mediation process is
provided by Preacher & Hayes.11
Table 6 Raw mediation statistics
Estimate (b) s.e. P 95% CI (lower) 95% CI (upper)
Low v. normal birth weight
Model without mediator
Intercept −1.18 0.01 <0.001 −1.20 −1.16
Low birth weight → MDD (Path c) 0.11 0.03 <0.001 0.05 0.17
Model with mediator
Intercept −2.17 0.02 <0.001 −2.21 −2.14
Low birth weight → neuroticism (Path a) 0.25 0.04 <0.001 0.16 0.33
Neuroticism → MDD (Path b) 0.22 0.00 <0.001 0.22 0.23
Low birth weight → MDD (Path c’) 0.07 0.03 0.040 0.00 0.13
Indirect effect (Paths a * b) 0.05 0.01 – 0.04 0.07
Very low v. normal birth weight
Model without mediator
Intercept −1.18 0.01 <0.001 −1.20 −1.16
Very low birth weight → MDD (Path c) 0.21 0.04 <0.001 0.14 0.29
Model with mediator
Intercept −2.18 0.02 <0.001 −2.12 −2.14
Very low birth weight → neuroticism (Path a) 0.26 0.06 <0.001 0.15 0.38
Neuroticism → MDD (Path b) 0.22 0.00 <0.001 0.22 0.23
Very low birth weight → MDD (Path c’) 0.18 0.04 <0.001 0.10 0.26
Indirect effect (Paths a * b) 0.06 0.01 – 0.03 0.09
Path a: association between predictor and mediator (i.e. low/very low birth weight → neuroticism).
Path b: the mediator→ outcome association (neuroticism → MDD) adjusted for the predictor (birth weight).
Path c: the ‘total effect’ of the predictor → outcome (low/very low birth weight → MDD).
Indirect effect: the product of Path a * Path b.
Path c’: the difference between Path c (‘total effect’) and the indirect effect (Path a * b).11,23
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associations were characterised by relatively small effect sizes:
around a 0.20–0.30 increase in neuroticism scores (out of 12) for
low/very low v. normal birth weight. Given the large sample size,
statistical significance may not be clinically meaningful, in terms
of being a risk factor for MDD/BD.
We found a significant association between low/very low birth
weight and increased risk of MDD. This survived adjustment for
potential confounding variables and physical disorder history.
There appeared to be dose effect, with lower birth weight being
associated with higher MDD rates. We found a similar dose effect
association for BD. When we separately contrasted very low and
low birth weight categories with normal birth weight, we found a
significant association between very low birth weight and risk of
BD in the unadjusted and confounder- but not mediator-adjusted
model (i.e. additionally corrected for physical disorders). Note that
sample sizes for the BD analyses were relatively small, and this
may contribute to non-significant P-values where the relevant
effect sizes are similar or even stronger than in the MDD results.
Interpretation
Publication bias was considered previously to have contributed to
over-representation of associations between lower birth weight and
MDD/depressive symptoms. Wojcik et al2 reported a relatively
weak association between lower birth weight and risk of MDD or
‘psychological distress’, which did not survive adjustment for
possible publication bias (OR=1.08, P>0.05). The current report
has several strengths relative to Wojcik et al’s meta-analysis: a large
sample size, greater than the combined total in the studies
summarised by Wojcik et al, a consistent classification method for
probable MDD/BD and detailed information of possible confoun-
ders. It therefore contributes a large amount of high-quality data to
the literature. The fact that the associations reported here between
MDD and birth weight survived adjustment for a history of physical
disorder known to be associated with low birth weight6,7 suggests
that the association is not entirely mediated through low birth
weight leading to increased risk of physical disorders, with
subsequent depression as a complication.
Our results in terms of neuroticism are relatively novel in that
they represent the first demonstration of association between lower
birth weight and higher neuroticism in a large sample, several
orders of magnitude greater than previous reports,3–5 although the
effect size is small. It will be important to replicate these findings in
large independent cohorts. Note that low birth weight was only
moderately associated with MDD, BD and higher neuroticism,
which might be because of measurement error (i.e. from errors in
birth weight recall), and the fact that low birth weight is only a blunt
indication of possible problems during fetal development.24 We had
no information on pregnancy complications or gestational age at
birth, which may also contribute to the association between birth
weight and deleterious outcomes;2 we therefore cannot identify low
birth weight because of preterm in this report.
Limitations and future research
The birth weight data in UK Biobank were obtained by asking the
participants to recall it in late adulthood. Whereas actual recorded
data would be preferable as recall will be subject to inherent noise/
error – Inskip et al24 showed that Bland-Altman plots revealed
reasonable agreement between the recalled weight (at assessment)
and recorded (hospital record-based) birth weights in 1729
women (Spearman rank r=0.87), although this was in young
women. This nonetheless suggests that recalled birth weight is
reasonably accurate; when people can recall their birth weight,
their recall is quite good, but many, of course, were excluded from
these analyses as their birth weight was unknown. It is possible
that certain recall biases influence our final results; for example,
perhaps participants with chronic illnesses are more likely to recall
information such as maternal depression or smoking. There was a
significant association between likelihood of reporting birth
weight (v. not) and probable MDD/BD; however, this was modest.
The present study corrects for several limitations compared
with the recent meta-analysis. However, there are additional
variables that were not accounted for, including gestational age,
maternal socioeconomic status and pregnancy-related complica-
tions such as preterm birth. The classification of probable MDD/BD
was based on self-report data which may be subject to under-
reporting. The current study does not take into account genetic
factors that may contribute to low birth weight or mood disorder,
potentially important variables such as parent’s socioeconomic
status, or whether parent’s attitudes or behaviours are different for
children with low birth weight.We did not control formultiple births
which may contribute to the prevalence of low birth weight in the
sample; however, we are not aware of multiple pregnancies being a
risk factor for MDD/neuroticism independent of any effect of low
birth weight, and it therefore might not act as a confounder.
Participants with lifetime histories of depression may have
been less likely to participate in UK Biobank research, and this
may interact with other variables such as lower socioeconomic
status; the sample may not be entirely representative of psychiatric
disease prevalence in a range of different backgrounds. Addition-
ally, developmental problems (such as low birth weight) may result
in a bias where the most impaired participants do not reach older
age or participate in research. We found a small but significant bias
where participants who reported birth weight data had higher
prevalence of MDD. This may reflect a degree of selection bias
where the participants that did not report birth weight data may
have a weaker weight/MDD association, which may partly attenuate
the relatively modest associations reported here.
Final summary
We have found significant associations between low/very low birth
weight and higher neuroticism and increased risk of MDD and
BD. In terms of MDD, our findings contribute significantly to the
literature, supporting the association reported in a recent meta-
analysis,2 which may have been somewhat weakened by hetero-
geneity between the 18 studies that were included. Our study
however did not control for pregnancy-related issues such as
preterm births (which may account for a degree of the association)
and future studies should attempt to take account of this. Our
findings support the hypothesis that fetal and early life factors
may have long-term effects on health across a broad range of
outcomes, including mental health outcomes, and lend support to
initiatives which target improved maternal health as a means for
improving the future health of offspring.25,26
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